BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 35368661)

  • 1. Identification of
    Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
    Front Genet; 2022; 13():810292. PubMed ID: 35368661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer.
    Luo Z; Chen Y; Chen B; Zhao Z; Wu R; Ren J
    BMC Med Genomics; 2024 Apr; 17(1):82. PubMed ID: 38581025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
    Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
    J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
    [No Abstract]   [Full Text] [Related]  

  • 4. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 5. THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer.
    Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
    Front Genet; 2022; 13():803460. PubMed ID: 35186032
    [No Abstract]   [Full Text] [Related]  

  • 6. GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration.
    Zhao W; Liang Z; Yao Y; Ge Y; An G; Duan L; Yao J
    Cancer Immunol Immunother; 2024 May; 73(7):131. PubMed ID: 38748299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 9. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
    Front Oncol; 2020; 10():603480. PubMed ID: 33425760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Expression of POSTN Predicts Poor Prognosis: a Potential Therapeutic Target for Gastric Cancer.
    Lu S; Peng L; Ma F; Chai J; Hua Y; Yang W; Zhang Z
    J Gastrointest Surg; 2023 Feb; 27(2):233-249. PubMed ID: 36451060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Feng L; Li G; Li D; Duan G; Liu J
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing.
    Chen M; Zhu X; Zhang L; Zhao D
    BMC Med Genomics; 2023 Sep; 16(1):220. PubMed ID: 37723519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma.
    Huang Y; Zhou H; Zou J; Wang D
    Can J Gastroenterol Hepatol; 2022; 2022():9983351. PubMed ID: 35257007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer.
    Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
    Front Genet; 2022; 13():765569. PubMed ID: 35154268
    [No Abstract]   [Full Text] [Related]  

  • 15. INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Yu W; He G; Zhang W; Ye Z; Zhong Z; Huang S
    Front Genet; 2022; 13():933862. PubMed ID: 36118865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Prolyl 4-Hydroxylase Subunit Alpha 3 Expression as an Independent Prognostic Biomarker and Correlated With Immune Infiltration in Gastric Cancer.
    Niu X; Ren L; Wang S; Gao D; Ma M; Hu A; Qi H; Zhang S
    Front Genet; 2022; 13():952335. PubMed ID: 35846138
    [No Abstract]   [Full Text] [Related]  

  • 19. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
    Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
    Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data.
    Xu SM; Xiao HY; Hu ZX; Zhong XF; Zeng YJ; Wu YX; Li D; Song T
    Front Oncol; 2023; 13():1162983. PubMed ID: 37091137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.